메뉴 건너뛰기




Volumn 12, Issue 2, 2013, Pages 177-182

Single high-dose oral vitamin D3 (stoss) therapy - A solution to vitamin D deficiency in children with cystic fibrosis?

Author keywords

Bone health; Cystic fibrosis; Stoss therapy; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL;

EID: 84878019148     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.08.007     Document Type: Article
Times cited : (37)

References (28)
  • 1
    • 7444255989 scopus 로고    scopus 로고
    • Treatment of bone disease in cystic fibrosis
    • Aris R., Lester G., Ontjes D. Treatment of bone disease in cystic fibrosis. Curr Opin Pulm Med 2004, 10:524-530.
    • (2004) Curr Opin Pulm Med , vol.10 , pp. 524-530
    • Aris, R.1    Lester, G.2    Ontjes, D.3
  • 2
    • 22144456751 scopus 로고    scopus 로고
    • Failure of high dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis
    • Boyle M., Noschese M., Watts S., Davis M., Stenner S., Lechtzin N. Failure of high dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis. Am J Respir Crit Care Med 2005, 172:212.
    • (2005) Am J Respir Crit Care Med , vol.172 , pp. 212
    • Boyle, M.1    Noschese, M.2    Watts, S.3    Davis, M.4    Stenner, S.5    Lechtzin, N.6
  • 3
    • 51449122068 scopus 로고    scopus 로고
    • Current treatment recommendations for correcting vitamin D deficiency in pediatric patients with cystic fibrosis are inadequate
    • Green D., Carson K., Leonard A., et al. Current treatment recommendations for correcting vitamin D deficiency in pediatric patients with cystic fibrosis are inadequate. J Pediatr 2008, 153:554-559.
    • (2008) J Pediatr , vol.153 , pp. 554-559
    • Green, D.1    Carson, K.2    Leonard, A.3
  • 4
    • 79952222282 scopus 로고    scopus 로고
    • Vitamin D deficiency in cystic fibrosis
    • Hall W., Sparks A., Aris R. Vitamin D deficiency in cystic fibrosis. Int J Endocrinol 2010, 218691.
    • (2010) Int J Endocrinol , pp. 218691
    • Hall, W.1    Sparks, A.2    Aris, R.3
  • 5
    • 20144389008 scopus 로고    scopus 로고
    • Consensus statement: guide to bone health and disease in cystic fibrosis
    • Aris R.M., Merkel P.A., Bachrach L.K., et al. Consensus statement: guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab 2005, 90(3):1888-1896.
    • (2005) J Clin Endocrinol Metab , vol.90 , Issue.3 , pp. 1888-1896
    • Aris, R.M.1    Merkel, P.A.2    Bachrach, L.K.3
  • 6
    • 22944488299 scopus 로고    scopus 로고
    • Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis
    • Buntain H., Greer R.M., Wong J.C.H., et al. Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis. J Paediatr Child Health 2005, 41:317-322.
    • (2005) J Paediatr Child Health , vol.41 , pp. 317-322
    • Buntain, H.1    Greer, R.M.2    Wong, J.C.H.3
  • 7
    • 0242288540 scopus 로고    scopus 로고
    • Comparison of low and high dose vitamin D treatment in nutritional vitamin D deficient rickets
    • Cesur Y., Caksen H., Gundem A., Kirimi E., Odabas D. Comparison of low and high dose vitamin D treatment in nutritional vitamin D deficient rickets. J Pediatr Endocrinol Metab 2003, 16:1105-1109.
    • (2003) J Pediatr Endocrinol Metab , vol.16 , pp. 1105-1109
    • Cesur, Y.1    Caksen, H.2    Gundem, A.3    Kirimi, E.4    Odabas, D.5
  • 8
    • 59849106269 scopus 로고    scopus 로고
    • A single high dose of ergocalciferol can be used to boost 25-hydroxyvitamin D levels in children
    • Belostotsky V., Mughal Z. A single high dose of ergocalciferol can be used to boost 25-hydroxyvitamin D levels in children. Pediatr Nephrol 2009, 24:625-626.
    • (2009) Pediatr Nephrol , vol.24 , pp. 625-626
    • Belostotsky, V.1    Mughal, Z.2
  • 9
    • 70350438305 scopus 로고    scopus 로고
    • Recognition and management of vitamin D deficiency
    • Bordelon P., Ghetu M., Langan R. Recognition and management of vitamin D deficiency. Am Fam Physician 2009, 80(8):841-846.
    • (2009) Am Fam Physician , vol.80 , Issue.8 , pp. 841-846
    • Bordelon, P.1    Ghetu, M.2    Langan, R.3
  • 10
    • 82455198590 scopus 로고    scopus 로고
    • Vitamin D deficiency as a risk factor for cystic fibrosis-related diabetes in the Scandinavian cystic fibrosis nutritional study
    • Pincikova T., Nilsson K., Moen I.E., et al. Vitamin D deficiency as a risk factor for cystic fibrosis-related diabetes in the Scandinavian cystic fibrosis nutritional study. Diabetologia 2011, 54(12):3007-3015.
    • (2011) Diabetologia , vol.54 , Issue.12 , pp. 3007-3015
    • Pincikova, T.1    Nilsson, K.2    Moen, I.E.3
  • 12
    • 21844460803 scopus 로고    scopus 로고
    • Annual intramuscular injection of megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data
    • Diamond T., Ho K., Rohl P., Meerkin M. Annual intramuscular injection of megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust 2005, 183(1):10-12.
    • (2005) Med J Aust , vol.183 , Issue.1 , pp. 10-12
    • Diamond, T.1    Ho, K.2    Rohl, P.3    Meerkin, M.4
  • 13
    • 79961102329 scopus 로고    scopus 로고
    • Mutations in CYP24A1 and idiopathic infantile hypercalcemia
    • Schlingmann K.P., Kaufmann M., Weber S., et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 2011, 365:410-421.
    • (2011) N Engl J Med , vol.365 , pp. 410-421
    • Schlingmann, K.P.1    Kaufmann, M.2    Weber, S.3
  • 14
    • 33748643014 scopus 로고    scopus 로고
    • Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement
    • Munns C., Zacharin M., Rodda C., et al. Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement. Med J Aust 2006, 185:268.
    • (2006) Med J Aust , vol.185 , pp. 268
    • Munns, C.1    Zacharin, M.2    Rodda, C.3
  • 16
    • 66749155389 scopus 로고    scopus 로고
    • Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol and UV light
    • Khazai N., Judd S., Jeng L., et al. Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol and UV light. J Clin Endocrinol Metab 2009, 94(6):2037-2043.
    • (2009) J Clin Endocrinol Metab , vol.94 , Issue.6 , pp. 2037-2043
    • Khazai, N.1    Judd, S.2    Jeng, L.3
  • 17
    • 34248336646 scopus 로고    scopus 로고
    • Cholecaliferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis
    • Stephenson A., Brotherwood M., Robert R., et al. Cholecaliferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis. Am J Clin Nutr 2007, 85:1307-1311.
    • (2007) Am J Clin Nutr , vol.85 , pp. 1307-1311
    • Stephenson, A.1    Brotherwood, M.2    Robert, R.3
  • 18
    • 36849052832 scopus 로고    scopus 로고
    • Vitamin D insufficiency in children, adolescents and young adults with cystic fibrosis despite routine oral supplementation
    • Rovner A., Stallings V., Schall J., Leonard M.B., Zemel B.S. Vitamin D insufficiency in children, adolescents and young adults with cystic fibrosis despite routine oral supplementation. Am J Clin Nutr 2007, 86:1694-1699.
    • (2007) Am J Clin Nutr , vol.86 , pp. 1694-1699
    • Rovner, A.1    Stallings, V.2    Schall, J.3    Leonard, M.B.4    Zemel, B.S.5
  • 19
    • 77953920571 scopus 로고    scopus 로고
    • Low vitamin D status: definition, prevalence, consequence and correction
    • Binkley N., Ramamurthy R., Krueger D. Low vitamin D status: definition, prevalence, consequence and correction. Endocrinol Metab Clin North Am 2010, 39:287-301.
    • (2010) Endocrinol Metab Clin North Am , vol.39 , pp. 287-301
    • Binkley, N.1    Ramamurthy, R.2    Krueger, D.3
  • 20
    • 80051535246 scopus 로고    scopus 로고
    • Appropriate goal level for 25-hydroxyvitamin D in cystic fibrosis
    • West N.E., Lechtzin N., Merlo C.A., et al. Appropriate goal level for 25-hydroxyvitamin D in cystic fibrosis. Chest 2011, 140:469-474.
    • (2011) Chest , vol.140 , pp. 469-474
    • West, N.E.1    Lechtzin, N.2    Merlo, C.A.3
  • 21
    • 0041705933 scopus 로고    scopus 로고
    • Abnormalities of the PTH-vitamin D axis and bone turnover marker in children, adolescents and adults with cystic fibrosis comparison with healthy controls
    • Greer R., Buntain H., Potter J., et al. Abnormalities of the PTH-vitamin D axis and bone turnover marker in children, adolescents and adults with cystic fibrosis comparison with healthy controls. Osteoporos Int 2003, 14:404-411.
    • (2003) Osteoporos Int , vol.14 , pp. 404-411
    • Greer, R.1    Buntain, H.2    Potter, J.3
  • 22
    • 67649494336 scopus 로고    scopus 로고
    • Very high dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis
    • Boas S., Hageman J., Ho L.T., Liveris M. Very high dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis. J Cyst Fibros 2009, 8:270-272.
    • (2009) J Cyst Fibros , vol.8 , pp. 270-272
    • Boas, S.1    Hageman, J.2    Ho, L.T.3    Liveris, M.4
  • 24
    • 58149166317 scopus 로고    scopus 로고
    • Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers
    • Grey V., Atkinson S., Drury D., et al. Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers. Pediatrics 2008, 122:1014-1020.
    • (2008) Pediatrics , vol.122 , pp. 1014-1020
    • Grey, V.1    Atkinson, S.2    Drury, D.3
  • 25
    • 84859556890 scopus 로고    scopus 로고
    • An update on the screening, diagnosis, management and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the cystic fibrosis foundation
    • Tangpricha V., Kelly A., Stephenson A., et al. An update on the screening, diagnosis, management and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the cystic fibrosis foundation. J Clin Endocrinol Metab 2012, 97(4):1082-1093.
    • (2012) J Clin Endocrinol Metab , vol.97 , Issue.4 , pp. 1082-1093
    • Tangpricha, V.1    Kelly, A.2    Stephenson, A.3
  • 26
    • 77955651358 scopus 로고    scopus 로고
    • Efficacy and safety of oral continuous low-dose versus short-term high-dose vitamin D: a prospective randomized trial conducted in a clinical setting
    • Hackman K.L., Gagnon C., Briscoe R.K., et al. Efficacy and safety of oral continuous low-dose versus short-term high-dose vitamin D: a prospective randomized trial conducted in a clinical setting. Med J Aust 2010, 192(12):686-689.
    • (2010) Med J Aust , vol.192 , Issue.12 , pp. 686-689
    • Hackman, K.L.1    Gagnon, C.2    Briscoe, R.K.3
  • 27
    • 77957812912 scopus 로고    scopus 로고
    • Effect of a single oral dose of 600 000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study
    • Cipriani C., Romagnoli E., Scillitani A., et al. Effect of a single oral dose of 600 000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metab 2010, 95(10):4771-4777.
    • (2010) J Clin Endocrinol Metab , vol.95 , Issue.10 , pp. 4771-4777
    • Cipriani, C.1    Romagnoli, E.2    Scillitani, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.